Literature DB >> 6643672

Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.

J M Aitken, P E Thornley.   

Abstract

Branhamella catarrhalis was suggested by the presence of gram-negative intracellular diplococci and confirmed by quantitative culture of the expectorated sputa of 11 patients with clinical evidence of lower respiratory tract infection. In quantitative culture, more than 20 colonies of B. catarrhalis were seen in each of the liquefied expectorated sputa at a dilution of 10(-7). Transtracheal aspirations were then performed on these 11 patients, and B. catarrhalis was isolated from the lower respiratory tract secretions of 10 of the patients. Of the 10 isolates, 5 produced beta-lactamase. None of the isolates grew on modified Thayer-Martin medium. The presence of gram-negative intracellular diplococci and the growth of B. catarrhalis on quantitative culture of expectorated sputum reliably indicates the presence of B. catarrhalis in the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643672      PMCID: PMC272879          DOI: 10.1128/jcm.18.5.1262-1263.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Acidometric agar plate method for ampicillin susceptibility testing of Haemophilus influenzae.

Authors:  C H Park; J S Lopez; C B Cook
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

2.  Improved medium selective for cultivation of N. gonorrhoeae and N. meningitidis.

Authors:  J D Thayer; J E Martin
Journal:  Public Health Rep       Date:  1966-06       Impact factor: 2.792

3.  Quantitation of microorganisms in sputum.

Authors:  P W Monroe; H G Muchmore; F G Felton; J K Pirtle
Journal:  Appl Microbiol       Date:  1969-08

4.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

5.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

  5 in total
  13 in total

1.  Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis.

Authors:  S M Ainsworth; S B Nagy; L A Morgan; G R Miller; J L Perry
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

2.  Mechanisms to assess Gram stain interpretation proficiency of technologists at satellite laboratories.

Authors:  Erik Munson; Timothy Block; Janice Basile; Jeanne E Hryciuk; Ronald F Schell
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 3.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

Authors:  T F Murphy
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 4.  Therapy of patients with resistant bacterial infections.

Authors:  J J Rahal
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 5.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Clinical features fail to distinguish respiratory infections caused by Branhamella catarrhalis from those caused by Haemophilus influenzae.

Authors:  K R Forward
Journal:  Can J Infect Dis       Date:  1992-01

Review 8.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

9.  Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.

Authors:  P E Thornley; J M Aitken; G M Nichol; N J Slevin
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.

Authors:  J A Pollard; R J Wallace; D R Nash; J I Luman; R W Wilson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.